5 Reasons Medical Marijuana, Inc. is Excited for the New Year

by adminTorusBrand | Jan 3, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Industry Updates, Kannalife Sciences

[vc_row][vc_column][vc_column_text]When looking back on 2016, it is hard to imagine a world where continued cannabis legalization, soaring cannabis approval ratings, and increased demand for cannabis research were not the norm. This year, the U.S. added four new...

Medical Marijuana, Inc.’s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlights Historic Year

by adminTorusBrand | Dec 28, 2016 | Axim Biotechnologies, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Kannaway, Press Releases

Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming Year SAN DIEGO, CA — (Marketwired) — 12/28/16 — Medical Marijuana, Inc.(OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States,...

Medical Marijuana, Inc. 2016 Year in Review

by adminTorusBrand | Dec 27, 2016 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Kannaway

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. and our portfolio of investments and subsidiaries had an enormous year in 2016. We began exporting our products to a number of new countries, created a market-first completely THC-free hemp-derived product,...

Medical Marijuana, Inc. Proudly Supports Research into Difficult to Treat Medical Conditions

by adminTorusBrand | Dec 9, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences

[vc_row][vc_column][vc_column_text]Medical Marijuana, Inc. and our portfolio of investment companies are using cannabinoids to research potential new treatments for a range of medical conditions, including those that have proven notoriously hard to treat....

Why Big Pharma is Scared of Cannabinoids – and How Medical Marijuana, Inc. is Bridging the Gap

by adminTorusBrand | Nov 11, 2016 | Axim Biotechnologies, Company News, Industry Updates, Kannalife Sciences

[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry’s growth – none more so than pharmaceuticals. This raises an...

Dr. Titus Insights: Biotechs and Cannabis

by adminTorusBrand | Sep 16, 2016 | Axim Biotechnologies, Company News, Dr. Titus Insights, Kannalife Sciences, Scientific Research

This week: GW Pharma has numerous acquisition offers from bigger pharma Insys Therapeutics Spends $500,000 to defeat cannabis recreational legalization in home state, Arizona Canada to ask the US to re-think its ludicrous border policy re cannabis usage Technical 420...